Skip to content
OpenCapital
Get started

Dianthus Therapeutics DNTH Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Travel + Leisure logo
Travel + LeisureTNL
18.8%+0.1pp
Belden logo
BeldenBDC
12.2%+0.5pp
Cabot Corporation logo
Cabot CorporationCBT
14.7%-6.0pp
Unifirst logo
UnifirstUNF
6.2%-0.9pp
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
3.4%+1.8pp
Liberty Broadband Corporation logo
Liberty Broadband CorporationLBRDK
-0.3%-0.1pp

Other financials

Income statement

See full
Revenue$396.0K-81.8%
Operating income-$46.5M-40.3%
Net income-$40.8M-38.4%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$627.7M+6,105%
Total debt$1.4M-2.3%
Total equity$1.2B+266%
Total assets$1.2B+258%

Cash flow

See full
Operating cash flow-$28.9M-4.4%
CapEx$10.0K-58.3%
Free cash flow-$28.9M-4.4%

Valuation

See full
Market cap$5.01B+823%
Enterprise value$4.38B+721%
P/S1,626.3×+1,068×

Profitability

See full
Operating margin-4,558.4%-9,354pp
Net margin-4,104.8%-7,304pp
FCF margin-3,561.6%-6,956pp

Returns & leverage

See full
Return on equity-28.6%+3.2pp
Debt / equity0×0.0×
Current ratio29.3×+13.3×

Where this comes from

Calculated from Dianthus Therapeutics’s reported figures.

$1.4Mtotal debt+$1.2Btotal stockholders equity−$627.7Mcash and equivalents=$575.01M

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dianthus Therapeutics's invested capital?
Dianthus Therapeutics (DNTH) reported invested capital of $575.01M in Q1 2026.
How has Dianthus Therapeutics's invested capital changed year-over-year?
Dianthus Therapeutics's invested capital increased by 79.8% year-over-year, from $319.89M to $575.01M.
What is the long-term trend for Dianthus Therapeutics's invested capital?
Over 3 years (2022 to 2025), Dianthus Therapeutics's invested capital has grown at a 146.1% compound annual growth rate (CAGR), from -$29.77M to $443.7M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).